生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | WT161 is a selective and potent HDAC6 inhibitor with IC50 value of 0.6nM, much potent to HDAC6 than HDAC1 (IC50=8.35nM) and HDAC2 (IC50=15.4nM). Inhibition of HDAC6 through WT161 at concentration ranging in 0.3-3μM dose-dependently up-regulated acetylation of tubulin in MM.1S cells post 6h. WT161 in combination with bortezomib triggered significant accumulation of polyubiquitinated proteins and cell stress, followed by caspase activation and apoptosis. And this combined treatment of WT161 (50mg/kg, i.p.) and bortezomib (0.5mg/kg, i.v.) for 26 days also inhibited tumor growth in SCID mice injected s.c. with MM.1S cells[3]. | ||
作用机制 | WT161 can interact with active site pocket of HDAC2, HDAC3, and HDAC6. It chelate the zinc ion through the hydroxamic acid.[3] |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.18mL 0.44mL 0.22mL |
10.90mL 2.18mL 1.09mL |
21.81mL 4.36mL 2.18mL |
参考文献 |
---|